Skip to main content
Erschienen in: Pathology & Oncology Research 2/2016

01.04.2016 | Research

Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma

verfasst von: Haibin Zeng, Zhong Zhang, Xiaoming Dai, Yongzhong Chen, Jianhua Ye, Zhixin Jin

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

MicroRNA (miR)-199b-5p has been reported to be upregulated in human osteosarcoma tissues and participate in the Notch signaling in osteosarcoma cells. This study was aimed to investigate the associations of miR-199b-5p expression with tumor progression of primary osteosarcoma, and to deepen the understanding of its involvement in carcinogenesis. Quantitative real-time reverse transcriptase-polymerase chain reaction was performed to detect expression levels of miR-199b-5p in 98 osteosarcoma and corresponding adjacent normal tissues. Then, the correlations of its expression with clinicopathological characteristics and patient prognosis were statistically analyzed. Moreover, in vitro assays were performed to assess the effects of miR-199b-5p on the proliferation, migration and invasion of two human osteosarcoma cell lines MG63 and U2OS. Compared to normal controls, miR-199b-5p expression was significantly upregulated in osteosarcoma tissues (P < 0.001). In addition, the expression levels of miR-199b-5p in osteosarcoma patients with high tumor grade (P = 0.008), positive metastasis (P = 0.001) and positive recurrence (P = 0.001) were markedly higher than those with low tumor grade, negative metastasis and negative recurrence. Moreover, osteosarcoma patients with high miR-199b-5p expression showed shorter overall survival (P < .001) and shorter disease-free survival (P < 0.001) than those with low expression. Furthermore, the inhibition of miR-199b-5p significantly suppressed cell proliferation, and reduced the migratory and invasive abilities of osteosarcoma cells. This study offer the convincing evidence for the first time that the increased expression of miR-199b-5p may play crucial roles in aggressive progression and poor prognosis of human osteosarcoma. miR-199b-5p may function as an oncogene by positively regulating the malignant potentials of this neoplasm.
Literatur
1.
Zurück zum Zitat Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9:422–441CrossRefPubMed Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9:422–441CrossRefPubMed
2.
Zurück zum Zitat Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G (2006) Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32:423–436CrossRefPubMed Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G (2006) Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32:423–436CrossRefPubMed
3.
Zurück zum Zitat Bielack SS, Marina N, Ferrari S (2008) Osteosarcoma: the same old drugs or more? J Clin Oncol 26:3102–3103CrossRefPubMed Bielack SS, Marina N, Ferrari S (2008) Osteosarcoma: the same old drugs or more? J Clin Oncol 26:3102–3103CrossRefPubMed
5.
6.
Zurück zum Zitat Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301:336–338CrossRefPubMed Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301:336–338CrossRefPubMed
7.
Zurück zum Zitat Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRefPubMed Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRefPubMed
8.
Zurück zum Zitat Brodersen P, Voinnet O (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10:141–148CrossRefPubMed Brodersen P, Voinnet O (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10:141–148CrossRefPubMed
9.
10.
11.
Zurück zum Zitat Ji F, Zhang H, Wang Y (2013) MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 56:220–226CrossRefPubMed Ji F, Zhang H, Wang Y (2013) MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 56:220–226CrossRefPubMed
12.
Zurück zum Zitat Pan W, Wang H, Jianwei R, Ye Z (2014) MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem 33:402–412CrossRefPubMed Pan W, Wang H, Jianwei R, Ye Z (2014) MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem 33:402–412CrossRefPubMed
13.
Zurück zum Zitat Novello C, Pazzaglia L, Cingolani C (2013) miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42:667–675PubMed Novello C, Pazzaglia L, Cingolani C (2013) miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42:667–675PubMed
14.
Zurück zum Zitat Zhang K, Zhang C, Liu L, Zhou J (2014) A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modulation of VEGF. Int J Clin Exp Pathol 7:5701–5708PubMedPubMedCentral Zhang K, Zhang C, Liu L, Zhou J (2014) A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modulation of VEGF. Int J Clin Exp Pathol 7:5701–5708PubMedPubMedCentral
15.
Zurück zum Zitat Shen L, Wang P, Yang J, Li X (2014) MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS ONE 9:e109138CrossRefPubMedPubMedCentral Shen L, Wang P, Yang J, Li X (2014) MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS ONE 9:e109138CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Geng S, Zhang X, Chen J, Liu X, Zhang H, Xu X, Ma Y, Li B, Zhang Y, Bi Z, Yang C (2014) The tumor suppressor role of miR-124 in osteosarcoma. PLoS ONE 9:e91566CrossRefPubMedPubMedCentral Geng S, Zhang X, Chen J, Liu X, Zhang H, Xu X, Ma Y, Li B, Zhang Y, Bi Z, Yang C (2014) The tumor suppressor role of miR-124 in osteosarcoma. PLoS ONE 9:e91566CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Flamant S, Ritchie W, Guilhot J (2010) Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 95:1325–1333CrossRefPubMedPubMedCentral Flamant S, Ritchie W, Guilhot J (2010) Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 95:1325–1333CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Garzia L, Andolfo I, Cusanelli E (2009) MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE 4:e4998CrossRefPubMedPubMedCentral Garzia L, Andolfo I, Cusanelli E (2009) MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE 4:e4998CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Won KY, Kim YW, Kim HS, Lee SK, Jung WW, Park YK (2013) MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. Hum Pathol 44:1648–1655CrossRefPubMed Won KY, Kim YW, Kim HS, Lee SK, Jung WW, Park YK (2013) MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. Hum Pathol 44:1648–1655CrossRefPubMed
20.
Zurück zum Zitat Fang C, Zhao Y, Guo B (2013) MiR-199b-5p targets HER2 in breast cancer cells. J Cell Biochem 114:1457–1463CrossRefPubMed Fang C, Zhao Y, Guo B (2013) MiR-199b-5p targets HER2 in breast cancer cells. J Cell Biochem 114:1457–1463CrossRefPubMed
21.
Zurück zum Zitat Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY, Chan DW (2014) Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer. Oncotarget 5:944–958CrossRefPubMedPubMedCentral Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY, Chan DW (2014) Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer. Oncotarget 5:944–958CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Li Z, Gu X, Fang Y, Xiang J, Chen Z (2012) microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 3:346–350PubMedPubMedCentral Li Z, Gu X, Fang Y, Xiang J, Chen Z (2012) microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 3:346–350PubMedPubMedCentral
23.
Zurück zum Zitat Li Y, Bai H, Zhang Z (2014) The up-regulation of miR-199b-5p in erythroid differentiation is associated with GATA-1 and NF-E2. Mol Cell 37:213–219CrossRef Li Y, Bai H, Zhang Z (2014) The up-regulation of miR-199b-5p in erythroid differentiation is associated with GATA-1 and NF-E2. Mol Cell 37:213–219CrossRef
24.
Zurück zum Zitat Bacci G, Bertoni F, Longhi A (2003) Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 97:3068–3075CrossRefPubMed Bacci G, Bertoni F, Longhi A (2003) Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 97:3068–3075CrossRefPubMed
25.
Zurück zum Zitat Favreau AJ, Cross EL, Sathyanarayana P (2012) miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol 87:442–446CrossRefPubMedPubMedCentral Favreau AJ, Cross EL, Sathyanarayana P (2012) miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol 87:442–446CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F (2010) MicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24:1363–1369PubMed Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F (2010) MicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24:1363–1369PubMed
27.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2 − ΔΔCt method. Methods 25:402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2 − ΔΔCt method. Methods 25:402–408CrossRefPubMed
28.
Zurück zum Zitat Andolfo I, Liguori L, De Antonellis P (2012) The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol 14:596–612CrossRefPubMedPubMedCentral Andolfo I, Liguori L, De Antonellis P (2012) The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol 14:596–612CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namløs HM, Meza-Zepeda LA, Myklebost O (2013) Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer 109:2228–2236CrossRefPubMedPubMedCentral Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namløs HM, Meza-Zepeda LA, Myklebost O (2013) Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer 109:2228–2236CrossRefPubMedPubMedCentral
Metadaten
Titel
Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma
verfasst von
Haibin Zeng
Zhong Zhang
Xiaoming Dai
Yongzhong Chen
Jianhua Ye
Zhixin Jin
Publikationsdatum
01.04.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2016
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-9901-3

Weitere Artikel der Ausgabe 2/2016

Pathology & Oncology Research 2/2016 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.